The latest report by IMARC Group, titled “Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the clinical nutrition market forecast.
Clinical Nutrition Market Analysis
The global clinical nutrition market size reached US$ 51.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 101.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Factors Affecting the Growth of the Clinical Nutrition Industry:
- Rising Chronic Diseases:
The increasing prevalence of chronic diseases such as diabetes, heart disease, and obesity is driving the demand for clinical nutrition products. These chronic conditions often require long-term management strategies that include dietary modifications and targeted nutritional support to improve patient outcomes. As more individuals are diagnosed with these conditions, there is a growing recognition of the role that tailored nutrition can play in managing symptoms, preventing complications, and enhancing overall quality of life. For instance, specialized nutritional formulations can help regulate blood sugar levels in diabetic patients or support cardiovascular health in those with heart disease. Furthermore, the rising awareness regarding the impact of diet on chronic disease management is leading healthcare providers to incorporate clinical nutrition into their treatment protocols.
- Advancements in Nutrition Science:
Advancements in nutrition science are playing a pivotal role in the development of more effective and personalized clinical nutrition products. As research in this field continues to evolve, it is leading to a deeper understanding of how specific nutrients can be used to manage various health conditions. This progress is facilitating the creation of nutritional products that are more efficacious and tailored to the unique needs of individual patients. For instance, innovations in nutrient delivery systems and the use of bioactive compounds are enhancing the bioavailability and therapeutic impact of clinical nutrition solutions. Moreover, the integration of genetic and metabolic profiling is enabling the development of personalized nutrition plans that cater to the specific health requirements of patients, making these products more appealing to healthcare providers and patients.
- Growing Healthcare Expenditure:
The rising healthcare expenditure globally is contributing to the increased adoption of clinical nutrition products. Additionally, clinical nutrition solutions are increasingly recognized as essential components of patient care, particularly for those with chronic conditions, where they can play a crucial role in disease management and recovery. Moreover, the growing investment in healthcare infrastructure, along with the expansion of health insurance coverage in various regions, is making these products more accessible to a broader population. Besides this, as healthcare providers aim to improve patient outcomes and reduce the long-term costs associated with chronic disease management, they are increasingly incorporating clinical nutrition into their standard care practices. Hence, this trend is driving the demand for a wide range of nutritional products, supporting the growth of the clinical nutrition market.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/clinical-nutrition-market/requestsample
Competitive Landscape:
The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Braun Melsungen AG
- BASF SE
- Baxter International Inc.
- Danone S.A.
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Koninklijke DSM N.V.
- Meiji Holdings Co. Ltd.
- Nestlé S.A.
- Perrigo Company plc
- Reckitt Benckiser Group PLC
Clinical Nutrition Market Report Segmentation:
By Product:
- Infant Nutrition
- Parental Nutrition
- Enteral Nutrition
Infant nutrition represents the largest segment due to the increasing demand for specialized formulas that support infant growth and development.
By Route Of Administration:
- Oral
- Enteral
- Parenteral
Oral accounts for the largest market share due to its ease of use and higher patient compliance.
By Application:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
On the basis of the application, the market has been classified into cancer, malnutrition, metabolic disorders, gastrointestinal disorders, neurological disorders, and others.
By End User:
- Pediatric
- Adults
- Geriatric
Pediatrics dominates the market growth due to the increasing prevalence of pediatric malnutrition and related health conditions.
Regional Insight:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Asia Pacific’s dominance in the clinical nutrition market is attributed to the rising birth rates, growing awareness about nutritional needs, and economic expansion in the area.
Global Clinical Nutrition Market Trends:
At present, tailored nutritional solutions based on individual health profiles are gaining traction. Additionally, companies are focusing on customized products that address specific health conditions and dietary needs. Moreover, there is a growing demand for clinical nutrition products designed for home use with more patients receiving care at home, including supplements and enteral nutrition solutions, thus contributing to the market growth. Besides this, the incorporation of digital tools such as mobile apps and wearable devices for monitoring dietary intake and health outcomes is influencing the market growth.
Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5995&flag=C
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
